Cargando…
Liver Injury in Favipiravir-Treated COVID-19 Patients: Retrospective Single-Center Cohort Study
(1) Background: Favipiravir (FVP) is a new antiviral drug used to treat COVID-19. It has been authorized to be used in the kingdom of Saudi Arabia in the treatment of COVID-19. The mechanism of action of FVP is working as a specific inhibitor for the RNA-dependent RNA polymerase of the RNA chain vir...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966436/ https://www.ncbi.nlm.nih.gov/pubmed/36828545 http://dx.doi.org/10.3390/tropicalmed8020129 |